European Medicines Agency Accepts MAA for Gout Drug

An immunotherapy treatment for gout is being tested for safety and efficacy.
An immunotherapy treatment for gout is being tested for safety and efficacy.
Lesinurad targets both excretion and production of uric acid.

The European Medicines Agency has accepted the marketing authorization application for lesinurad (AstraZeneca), a gout treatment. According to results from some Phase 3 trials, lesinurad dropped the uric acid, which has been linked with painful gout flare-ups.

READ FULL ARTICLE Curated publisher From FierceBiotech